Figure 1 | Detection of genomic EBOV RNA in the eyes of rhesus monkey survivors by in situ hybridization. Genomic EBOV RNA (red) detected by ISH using an EBOV NP gene-specific probe in haematoxylin-stained (blue) FFPE sections. Single prime figures a′–e′ are insets of a–e at high magnification.
Figure 2 | Ocular macrophages of survivors express EBOV GP1,2 antigen. a, EBOV GP1,2 antigen (red) staining in a cluster of likely inflammatory cells, including macrophages adjacent to the inner limiting membrane of the retina (labelled using a GFAP antibody, green). Blue DAPI stain identifies nuclei .
Figure 4 | Ebola virus persistence in the brain of a rhesus monkey survivor.
a, EBOV genomic RNA detection by ISH in a glial nodule in the corpus striatum of brain. Inset: image at high magnification (scale bar, 100 μm). b–b‴, Immunofluorescence staining reveals EBOV GP1,2 antigen (green) in CD68+ microglia(red) or extracellularly within a glial nodule (scale bars, 50 μm (b) and 5 μm (b‴)). Blue, nuclear stain by DAPI.
Figure 6 | EBOV replicates in the eyes, epididymides and brains of rhesus monkey survivors. a–f‴, Multiplex FISH was used to detect EBOV genome (red) and antigenome/mRNA (green) in eyes (a–d‴), tubular lumen of the epididymis (e–e‴) and brain (f–f‴) (scale bars, 10 μm (c′,d‴,e‴,f‴), 20 μm (a,b′,c,d), 50 μm (b,f), 100 μm in (e)). Blue, nuclear stain by DAPI. g, Quantification of the FISH intensity ratio between EBOV antigenome/mRNA and genome signals.Data are presented as mean ± s.e.m. (n = 13, 32, 36, 22).
【ABSTRACT】
Ebola virus (EBOV) persistence inasymptomatic humans and Ebola virus disease (EVD) sequelae have emerged assignificant public health concerns since the 2013–2016 EVD outbreak in WesternAfrica. Until now, studying how EBOV disseminates into and persists inimmune-privileged sites was impossible due to the absence of a suitable animalmodel. Here, we detect persistent EBOV replication coinciding with systematicinflammatory responses in otherwise asymptomatic rhesus monkeys that hadsurvived infection in the absence of or after treatment with candidate medicalcountermeasures. We document progressive EBOV dissemination into the eyes, brainand testes through vascular structures, similar to observations in humans. Weidentify CD68+ cells (macrophages/monocytes) as the cryptic EBOV reservoircells in the vitreous humour and its immediately adjacent tissue, in thetubular lumina of the epididymides, and in foci of histiocytic inflammation inthe brain, but not in organs typically affected during acute infection. Inconclusion, our data suggest that persistent EBOV infection in rhesus monkeyscould serve as a model for persistent EBOV infection in humans, and wedemonstrate that promising candidate medical countermeasures may not completelyclear EBOV infection. A rhesus monkey model may lay the foundation to study EVDsequelae and to develop therapies to abolish EBOV persistence.
原文链接:
Xiankun Zeng, Candace D. Blancett, Keith A. Koistinen,Christopher W. Schellhase, Jeremy J. Bearss, Sheli R. Radoshitzky, Shelley P.Honnold, Taylor B. Chance, Travis K. Warren, Jeffrey W. Froude, Kathleen A.Cashman, John M. Dye, Sina Bavari, Gustavo Palacios, Jens H. Kuhn & Mei G.Sun.Identification and pathological characterization of persistent asymptomaticEbola virus infection in rhesus monkeys Nature Microbiology, (2017).
doi:10.1038/nmicrobiol.2017.113作者: cao1976 时间: 2017-7-20 09:42
附全文下载链接:http://pan.baidu.com/s/1o8ukZhw